Form 8-K - Current report:
SEC Accession No. 0001558370-25-005157
Filing Date
2025-04-22
Accepted
2025-04-22 17:07:13
Documents
14
Period of Report
2025-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250416x8k.htm   iXBRL 8-K 38484
  Complete submission text file 0001558370-25-005157.txt   165782

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20250416.xsd EX-101.SCH 4266
3 EX-101.DEF chrs-20250416_def.xml EX-101.DEF 3159
4 EX-101.LAB chrs-20250416_lab.xml EX-101.LAB 15908
5 EX-101.PRE chrs-20250416_pre.xml EX-101.PRE 10736
16 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250416x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 25858449
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)